An upregulation of the protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway is frequently detected in ccRCC in humans, and is associated with related metabolic alterations like increased glycolysis and lipogenesis [2,3]. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.